Plenvu Kit
Product Images NDC 65649-400

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Plenvu (NDC 65649-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

One Day Dose 2 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 00)

An instructional illustration showing the preparation of Plenvu kit's dose 2 by pouring the contents of Pouch A and Pouch B into a container filled with water. The image outlines the combination of both pouches into the mixing vessel as part of the kit's use.*

FDA Label Image

One Day Step 3 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 01)

An instructional illustration depicting a person filling a cup to a specified line with water from a faucet, then drinking from the cup. The image emphasizes the action of filling the cup to the indicated level before consumption.*

FDA Label Image

One Day Step 2 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 02)

A black and white instructional illustration showing a simplified human figure holding a glass and drinking from it. The image conveys the action of taking a liquid orally, likely indicating medication administration.*

FDA Label Image

One Day Step 1c (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 03)

An instructional illustration showing two methods for preparing a solution: mixing by stirring with a spoon in a glass and shaking a capped container. The image demonstrates the options for mixing a liquid product before use.*

FDA Label Image

One Day Step 1b (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 04)

Illustration showing a glass under a water tap with a fill line indicated, and a tablet or pill placed next to the glass. The image likely instructs to fill the glass with water up to the marked line before dissolving the tablet.*

FDA Label Image

One Day Step 1a (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 05)

An instructional illustration showing a packet labeled 'DOSE 1' being poured into a glass of water with effervescent bubbles, with a bottle cap placed beside the glass. It demonstrates the preparation step for a dose of Plenvu kit.*

FDA Label Image

Dose 2 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 06)

An instructional diagram depicting two dosed pouches labeled 'Dose 2 Pouch A' and 'Dose 2 Pouch B' being poured simultaneously into a glass or container. A small circular object, possibly a cap or lid, is shown next to the glass.*

FDA Label Image

Step 3 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 07)

An instructional diagram illustrating the preparation and consumption steps: a container is shown being filled with water to a marked line from a faucet; an arrow points to a person holding and drinking from a glass, indicating to drink the prepared solution.*

FDA Label Image

Step 2 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 08)

Instructional icon showing a simplified figure drinking from a cup or glass, indicating oral administration or ingestion.*

FDA Label Image

Step 1c (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 09)

An instructional illustration showing two ways to prepare a liquid medication: one side depicts stirring with a spoon in a glass labeled 'MIX', and the other side shows shaking a container labeled 'SHAKE'. Both methods are presented as options with the word 'OR' between them.*

FDA Label Image

Step 1b (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 10)

An instructional diagram showing a faucet filling a transparent container with liquid to a marked fill line. Next to the container is a tablet shown separately, indicating preparation steps involving dissolving the tablet in water up to the fill line.*

FDA Label Image

Step 1a (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 11)

An instructional illustration depicting the process of adding Dose 1 powder to a container or cup, shown pouring from a labeled packet into a partially filled cup. A cap or lid is placed beside the container, indicating it may be used later to seal or mix the contents. The image is part of preparation instructions for the medication kit Plenvu by Salix Pharmaceuticals, Inc.*

FDA Label Image

Dose 2 A And B (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 12)

Packaging label image of Plenvu kit components showing two dose 2 pouches labeled A and B. The image depicts individual pouches as part of the Plenvu human prescription drug kit by Salix Pharmaceuticals, Inc.*

FDA Label Image

Dose 1 (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 13)

Plenvu kit label panel showing a rectangular section marked 'Dose 1'. No other visible text or detail is present in the image.*

FDA Label Image

Pi And Ppi (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 14)

A text panel titled 'PLENVU Prescribing Information and Patient Information.' The panel appears to be the cover page for prescribing and patient information for the drug Plenvu, a kit by Salix Pharmaceuticals, Inc.*

FDA Label Image

Mixing Container (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 15)

An illustration of a medication bottle with a child-resistant cap, showing a dashed line indicating a fill or dosage level. The image likely relates to dosing or administration instructions.*

FDA Label Image

Inner Carton (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 16)

Packaging label illustration of Plenvu kit by Salix Pharmaceuticals, Inc. The image shows a rectangular box with the brand name Plenvu printed on the front and side panels in a simple, modern font. No additional text, dosage strengths, or graphics are visible on the box in the black-and-white line drawing.*

FDA Label Image

Outer Carton (3bbbfd09 4f0b 4d76 Ab63 240307c8098d 17)

Packaging label for Plenvu kit, a human prescription drug by Salix Pharmaceuticals, Inc. The black-and-white image shows a rectangular box with the proprietary name Plenvu printed on three visible sides of the carton. The image does not display additional text, active ingredients, or dosage details.*

FDA Label Image

Table3image1 (Image 01)

Chemical structure diagram of polyethylene glycol, showing repeating ethylene glycol units with terminal hydroxyl groups, representing the active ingredient in Plenvu.*

FDA Label Image

Table3image2 (Image 02)

Chemical structure of sodium ascorbate, one of the active ingredients in Plenvu, shown with atomic bonds and functional groups including hydroxyl and carboxylate moieties.*

FDA Label Image

Table3image3 (Image 03)

Chemical structure diagram showing the sulfate ion with two sodium ions (Na+) associated, representing part of the sodium sulfate component in the active ingredients of Plenvu.*

FDA Label Image

Table3image4 (Image 04)

Chemical structure diagram of ascorbic acid, one of the active ingredients in Plenvu, showing its molecular arrangement with hydroxyl groups and a lactone ring.*

FDA Label Image

Carton (Image 05)

The image shows a flat layout of the Plenvu kit packaging. Plenvu contains polyethylene glycol 3350, sodium ascorbate, sodium sulfate, sodium chloride, potassium chloride, and ascorbic acid. Labeling includes instructions for use, dosage details indicating Dose 1 and Dose 2 content, and manufacturer information showing Salix Pharmaceuticals, Inc. The packaging features the product name with strength details and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.